China, Korean Associations Ink Co-op Deal On Biopharma R&D
This article was originally published in PharmAsia News
Executive Summary
China Medicinal Biotech Association and Korea Biotechnology Industry Organization (KoBIA) have sealed a biopharma cooperation agreement for sharing R&D results, irregular exchanges and potential R&D collaboration.